Dulloo, A. G. and Miller, D. S. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture. J Nutr 1987;117(2):383-389. View abstract.
Dulloo, A. G. and Miller, D. S. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies. Am J Clin Nutr 1986;43(3):388-394. View abstract.
Dulloo, A. G. and Miller, D. S. Thermogenic drugs for the treatment of obesity: sympathetic stimulants in animal models. Br J Nutr 1984;52(2):179-196. View abstract.
Dulloo, A. G. Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. Int J Obes.Relat Metab Disord. 1993;17 Suppl 1:S35-S40. View abstract.
Dulloo, A. G. Herbal simulation of ephedrine and caffeine in treatment of obesity. Int.J.Obes.Relat Metab Disord. 2002;26(5):590-592. View abstract.
Dulloo, A. G., Seydoux, J., and Girardier, L. Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition? Metabolism 1992;41(11):1233-1241. View abstract.
Faurschou, M. and Svendsen, U. G. [The bronchodilating effect of ephedrine tablets in bronchial asthma]. Ugeskr.Laeger 11-15-1993;155(46):3784-3785. View abstract.
Flanagan, C. M., Kaesberg, J. L., Mitchell, E. S., Ferguson, M. A., and Haigney, M. C. Coronary artery aneurysm and thrombosis following chronic ephedra use. Int.J.Cardiol. 2-18-2010;139(1):e11-e13. View abstract.
May, C. S., Pickup, M. E., and Paterson, J. W. The acute and chronic bronchodilator effects of ephedrine in asthmatic patients. Br J Clin Pharmacol 1975;2(6):533-537. View abstract.
Matev, M., Chakurski, I., Stefanov, G., Koichev, A., and Angelov, I. [Use of an herbal combination with laxative action on duodenal peptic ulcer and gastroduodenitis patients with a concomitant obstipation syndrome]. Vutr.Boles. 1981;20(6):48-51. View abstract.
Siegers, C. P., Hertzberg-Lottin, E., Otte, M., and Schneider, B. Anthranoid laxative abuse--a risk for colorectal cancer? Gut 1993;34(8):1099-1101. View abstract.
van Gorkom, B. A., de Vries, E. G., Karrenbeld, A., and Kleibeuker, J. H. Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment.Pharmacol Ther 1999;13(4):443-452. View abstract.
Willems, M., van Buuren, H. R., and de, Krijger R. Anthranoid self-medication causing rapid development of melanosis coli. Neth.J Med 2003;61(1):22-24. View abstract.
Chakurski I, Matev M, Koichev A, et al. [Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare]. Vutr Boles. 1981;20:51-4. View abstract.
De Kort H, Mergeay J, Jacquemyn H, Honnay O. Transatlantic invasion routes and adaptive potential in North American populations of the invasive glossy buckthorn, Frangula alnus. Ann Bot. 2016;118(6):1089-1099. View abstract.
Nusko G, Schneider B, Schneider I, et al. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut 2000;46:651-5. View abstract.
Young DS. Effects of Drugs on Clinical Laboratory Tests 4th ed. Washington: AACC Press, 1995.